Freshpet Lifts 2026 Sales Outlook After Q3 Beat, Margins Expand
FRPT sits 49% above its 52-week low of $46.45.
Summary
Q3 came in ahead of estimates: EPS of 58 cents versus 43 cents expected and sales up 10.0% to $317.8 million against a $312.0 million consensus. The bigger item is guidance — Freshpet raised fiscal 2026 sales to $1.234-$1.245 billion from $1.212-$1.234 billion, narrowed adjusted EBITDA to $215-$220 million and narrowed 2026 capex to $125-$150 million from ~$150 million, while reiterating 2027 targets of at least 49% adjusted gross margin and 20%-22% adjusted EBITDA margin. Margins are doing the work: gross margin jumped to 44.5% from 39.5% and adjusted gross margin to 50.0% from 46.0%, with adjusted EBITDA of $64.5 million (20.3% margin) versus $54.6 million a year ago. Net income of $27.9 million looks like a steep drop from $101.7 million, but last year's quarter carried a $77.9 million deferred tax benefit. Management said new entrants aren't denting sales or retention, and it expects the new bag technology to add more than 100 basis points of adjusted gross margin once optimized. The catch: if inflation doesn't ease, they expect to land in the lower half of the 20%-22% 2027 EBITDA margin range and will take selective price increases. Shares are down 2.39% at $67.94 despite the beat and raise.
Updated with an SEC 8-K filing · What changed
Updates
· SEC 8-K — Freshpet narrowed 2026 capex guidance to $125-$150 million from ~$150 million and reiterated 2027 targets of at least 49% adjusted gross margin and 20%-22% adjusted EBITDA margin.
At the time of this announcement, FRPT was trading at $69.30 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $3.3B. The 52-week trading range was $46.45 to $86.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Benzinga.